Grammer Balans Gezondheid

Financiële gezondheid criteriumcontroles 1/6

Grammer heeft een totaal eigen vermogen van €222.8M en een totale schuld van €489.9M, wat de schuld-eigenvermogensverhouding op 219.9% brengt. De totale activa en totale passiva bedragen respectievelijk €1.5B en €1.3B.

Belangrijke informatie

219.9%

Verhouding schuld/eigen vermogen

€489.90m

Schuld

Rente dekkingsratio	n/a
Contant	€103.43m
Aandelen	€222.82m
Totaal verplichtingen	€1.30b
Totaal activa	€1.52b

Recente financiële gezondheidsupdates

Recent updates

Here's Why Grammer (ETR:GMM) Is Weighed Down By Its Debt Load

Aug 06

We Discuss Why Grammer AG's (ETR:GMM) CEO Compensation May Be Closely Reviewed

May 29

Is Grammer (ETR:GMM) Using Too Much Debt?

Jul 24

Is Grammer (ETR:GMM) Using Debt Sensibly?

Jan 12

Does Grammer (ETR:GMM) Have A Healthy Balance Sheet?

Jul 08

When Should You Buy Grammer AG (ETR:GMM)?

Dec 06

Shareholders Will Be Pleased With The Quality of Grammer's (ETR:GMM) Earnings

Aug 19

Is Grammer (ETR:GMM) Using Too Much Debt?

Jun 02

Is Grammer AG (ETR:GMM) Trading At A 32% Discount?

May 03

Earnings Update: Here's Why Analysts Just Lifted Their Grammer AG (ETR:GMM) Price Target To €28.25

Apr 03

Does Grammer (ETR:GMM) Have A Healthy Balance Sheet?

Jan 29

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €670.7M ) van GMM } dekken niet de korte termijn passiva ( €706.4M ).

Langlopende schulden: De kortetermijnactiva GMM ( €670.7M ) overtreffen de langetermijnschulden ( €593.7M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 173.5% ) GMM wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van GMM is de afgelopen 5 jaar gestegen van 133% naar 219.9%.

Schuldendekking: De schuld van GMM wordt niet goed gedekt door de operationele kasstroom ( 3% ).

Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van GMM op haar schulden goed worden gedekt door EBIT.

Grammer Balans Gezondheid

Financiële gezondheid criteriumcontroles 1/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Here's Why Grammer (ETR:GMM) Is Weighed Down By Its Debt Load

Is Grammer (ETR:GMM) Using Too Much Debt?

Is Grammer (ETR:GMM) Using Debt Sensibly?

Does Grammer (ETR:GMM) Have A Healthy Balance Sheet?

Is Grammer (ETR:GMM) Using Too Much Debt?

Does Grammer (ETR:GMM) Have A Healthy Balance Sheet?

Recent updates

Grammer AG to Report Fiscal Year 2024 Results on Mar 28, 2025

New minor risk - Market cap size

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: €0.45 (vs €0.24 loss in 2Q 2023)

Here's Why Grammer (ETR:GMM) Is Weighed Down By Its Debt Load

We Discuss Why Grammer AG's (ETR:GMM) CEO Compensation May Be Closely Reviewed

First quarter 2024 earnings released: €0.43 loss per share (vs €0.19 profit in 1Q 2023)

New minor risk - Share price stability

Full year 2023 earnings released: EPS: €0.12 (vs €5.26 loss in FY 2022)

Grammer AG to Report Q3, 2024 Results on Oct 29, 2024

Grammer AG, Annual General Meeting, Jun 04, 2024

Grammer AG Provides Earnings Forecast for 2023

Grammer AG to Report Q2, 2024 Results on Aug 14, 2024

Third quarter 2023 earnings released: EPS: €0.037 (vs €0.65 in 3Q 2022)

Grammer AG Provides Earnings Guidance for the Fourth Quarter and Full Year of 2023

Second quarter 2023 earnings released: €0.90 loss per share (vs €1.14 loss in 2Q 2022)

New minor risk - Share price stability

Is Grammer (ETR:GMM) Using Too Much Debt?

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased by 15% to €16.65

Is Grammer (ETR:GMM) Using Debt Sensibly?

Price target decreased to €19.50

Third quarter 2022 earnings released: EPS: €0.75 (vs €0.30 loss in 3Q 2021)

Grammer AG to Report First Half, 2023 Results on Aug 14, 2023

Grammer AG to Report Q3, 2022 Results on Oct 27, 2022

Second quarter 2022 earnings released: €1.21 loss per share (vs €0.33 profit in 2Q 2021)

Price target decreased to €19.50

Does Grammer (ETR:GMM) Have A Healthy Balance Sheet?

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Grammer Ag Announces Resignation of Executives

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Grammer AG Provides Earnings Guidance for the Fiscal Year 2022

Investor sentiment deteriorated over the past week

When Should You Buy Grammer AG (ETR:GMM)?

Shareholders Will Be Pleased With The Quality of Grammer's (ETR:GMM) Earnings

Second quarter 2021 earnings released: EPS €0.33 (vs €4.02 loss in 2Q 2020)

Grammer AG Provides Earnings Guidance for the Second Quarter of 2021

Is Grammer (ETR:GMM) Using Too Much Debt?

Is Grammer AG (ETR:GMM) Trading At A 32% Discount?

First quarter 2021 earnings released: EPS €0.88 (vs €0.80 loss in 1Q 2020)

Full year 2020 earnings released: €5.10 loss per share (vs €3.56 profit in FY 2019)

Grammer AG Provides Consolidated Earnings Guidance for the First Quarter 2021 and Full Year 2021

Earnings Update: Here's Why Analysts Just Lifted Their Grammer AG (ETR:GMM) Price Target To €28.25

Grammer AG to Report Q2, 2021 Results on Aug 05, 2021

New 90-day high: €24.20

Does Grammer (ETR:GMM) Have A Healthy Balance Sheet?

Price target raised to €19.25

Grammer AG to Report Fiscal Year 2020 Results on Mar 31, 2021

The Grammer Group Announces Long-Term Partnership with Harman International Industries

Grammer AG Provides Earnings Guidance for the Year 2020

New 90-day low - €15.55

Analysts lower EPS estimates to -€3.51

Earnings released

New 90-day low - €16.65

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven